Clinical Trials
3
Active:0
Completed:2
Trial Phases
3 Phases
Early Phase 1:1
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (33.3%)Phase 1
1 (33.3%)Phase 2
1 (33.3%)Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- OliPass Corporation
- Target Recruit Count
- 134
- Registration Number
- NCT05216341
- Locations
- 🇦🇺
Northern Beaches Clinical Research, Brookvale, New South Wales, Australia
🇦🇺Novatrials, Kotara, New South Wales, Australia
🇦🇺Sutherland Shire Clinical Research, Miranda, New South Wales, Australia
OLP-1002 is Being Studied in the Treatment of Pain.
Early Phase 1
Completed
- Conditions
- Pain
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- OliPass Corporation
- Target Recruit Count
- 116
- Registration Number
- NCT03760913
- Locations
- 🇬🇧
Leeds CRU, Leeds, United Kingdom
News
No news found